Summary
Seizures in older individuals are frequently due to cerebrovascular disease, though other causes, such as primary or metastic brain tumour, must be considered. Recurrence after a first seizure may be as high as 83% by 3 years, suggesting that withholding an anticonvulsant after a first seizure may not be wise. Some older patients may be more sensitive to anticonvulsant side effects, so treatment with 1 drug is encouraged, with monitoring of blood concentrations of the anticonvulsant during initiation of therapy. Interaction of anticonvulsants with other drugs is less of a problem than may be expected, but should be kept in mind. The treatment of status epilepticus should be aggressive.
Similar content being viewed by others
References
Bleck TP. Convulsive disorders: the use of anticonvulsant drugs. Clinical Neuropharmacology 13: 198–209, 1990
Bruni J, Albright PS. The clinical pharmacology of antiepileptic drugs. Clinical Neuropharmacology 7: 1–34, 1984
Bryson SM, Verma N, Scott PJW, Rubin PC. Pharmacokinetics of valproic acid in young and elderly subjects. British Journal of Clinical Pharmacology 16: 104–105, 1983
Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22: 489–501, 1981
Crooks J, O’Malley K, Stevenson IH. Pharmacokinetics in the elderly. Clinical Pharmacokinetics 1: 180–296, 1976
Duncan JS, Patsalos PN, Shorvon SD. Effects of discontinuation of phenytoin, carbamazepine, and valproate on concomitant antiepileptic medication. Epilepsia 32: 101–115, 1991
Hart YM, Sander JWAS, Johnson AL, Shorvon SD. National general practice study of epilepsy: recurrence after a first seizure. Lancet 336: 1271–1274, 1990
Hauser A, Kurland LT. The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 16: 1–66, 1975
Hockings N, Pall A, Moody J, Davidson AVM, Davidson DLW. The effects of age on carbamazepine pharmacokinetics and adverse effects. British Journal of Clinical Pharmacology 22: 725–728, 1986
Jüül-Jensen P. Frequency of recurrence after discontinuance of anticonvulsant therapy in patients with epileptic seizures. Epilepsia 5: 352–363, 1964
Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Penry JK (Eds) Antiepileptic drugs, 3rd ed., Raven Press, New York, 1989
Loiseau J, Loiseau P, Duche B, Guyot M, Dartigues J-F, et al. A survey of epileptic disorders in southwest France: seizures in elderly patients. Annals of Neurology 27: 232–237, 1990
Luhdorf K, Jensen LK, Plesner AM. Etiology of seizures in the elderly. Epilepsia 27: 458–463, 1986
Perucca E, Grimaldi R, Gatti G, Pirrachhio S, Crema F, et al. Pharmokinetics of valproic acid in the elderly. British Journal of Clinical Pharmacology 17: 665–669, 1984
Rashkin MC, Youngs C, Penovich P. Pentobarbital treatment of refractory status epilepticus. Neurology 37: 500–503, 1987
Richey DP, Bender AD. Pharmacokinetic consequences of aging. Annual Review of Pharmacology and Toxicology 17: 49–65, 1977
Ring HA, Heller AJ, Farr IN, Reynolds EH. Vigabatrin: rational treatment for chronic epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 53: 1051–1055, 1990
Roberts RC, Shorvon SD, Cox TCS, Gilliatt RW. Clinically unsuspected cerebral infarction revealed by computer tomography scanning in late onset epilepsy. Epilepsia 29: 190–194, 1988
Sander JWAS, Hart YM, Johnson AL, Shorvon SD. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 336: 1267–1271, 1990
Schmucker DL. Aging and drug disposition: an update. Pharmacological Reviews 37: 133–148, 1985
Schmidt D. Reduction of two-drug therapy in intractable epilepsy. Epilepsia 24: 368–376, 1983
Shorvon SD, Gilliatt RW, Cox TCS, Yu YL. Evidence of vascular disease from CT scanning in late onset epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 47: 225–230, 1984
Sung C-Y, Chu N-S. Status epilepticus in the elderly: etiology, seizure type and outcome. Acta Neurologica Scandinavica 80: 51–56, 1989
Swanson PD. Anticonvulsant therapy. Postgraduate Medicine 65: 147–154, 1979
Tallis R. Epilepsy in old age. Lancet 336: 295–296, 1990
Traeger A, Kiesewetter R, Kunze M. Zur Pharmakokinetik von Phenobarbital bei Erwachsenen und Greisen. Deutsche Gesundheitswesen 29: 1040–1042, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Swanson, P.D. Treatment Recommendations for Anticonvulsant Drug Therapy in the Older Patient. Drugs & Aging 2, 95–102 (1992). https://doi.org/10.2165/00002512-199202020-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199202020-00003